Who makes Ipratropium Bromide 20Micrograms Inhaler?

Ipratropium Bromide 20Micrograms Inhaler is developed by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina.

What development phase is Ipratropium Bromide 20Micrograms Inhaler in?

Ipratropium Bromide 20Micrograms Inhaler is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · FDA-approved active Small molecule Quality 3/100

Generic name	Ipratropium Bromide 20Micrograms Inhaler
Also known as	Anticholinergic
Sponsor	Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Modality	Small molecule
Phase	FDA-approved

No approved indications tracked.

No common side effects on file.

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results